Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Neutrophil extracellular traps mediate articular cartilage damage and enhance cartilage component immunogenicity in rheumatoid arthritis
Carmelo Carmona-Rivera, Philip M. Carlucci, Rishi R. Goel, Eddie James, Stephen R. Brooks, Cliff Rims, Victoria Hoffmann, David A. Fox, Jane H. Buckner, Mariana J. Kaplan
Carmelo Carmona-Rivera, Philip M. Carlucci, Rishi R. Goel, Eddie James, Stephen R. Brooks, Cliff Rims, Victoria Hoffmann, David A. Fox, Jane H. Buckner, Mariana J. Kaplan
View: Text | PDF
Research Article

Neutrophil extracellular traps mediate articular cartilage damage and enhance cartilage component immunogenicity in rheumatoid arthritis

  • Text
  • PDF
Abstract

Rheumatoid arthritis (RA) is characterized by synovial joint inflammation, cartilage damage, and dysregulation of the adaptive immune system. While neutrophil extracellular traps (NETs) have been proposed to play a role in the generation of modified autoantigens and in the activation of synovial fibroblasts, it remains unknown whether NETs are directly involved in cartilage damage. Here, we report a new mechanism by which NET-derived elastase disrupts cartilage matrix and induces release of membrane-bound peptidylarginine deiminase-2 by fibroblast-like synoviocytes (FLSs). Cartilage fragments are subsequently citrullinated, internalized by FLSs, and then presented to antigen-specific CD4+ T cells. Furthermore, immune complexes containing citrullinated cartilage components can activate macrophages to release proinflammatory cytokines. HLA-DRB1*04:01 transgenic mice immunized with NETs develop autoantibodies against citrullinated cartilage proteins and display enhanced cartilage damage. Inhibition of NET-derived elastase rescues NET-mediated cartilage damage. These results show that NETs and neutrophil elastase externalized in these structures play fundamental pathogenic roles in promoting cartilage damage and synovial inflammation. Strategies targeting neutrophil elastase and NETs could have a therapeutic role in RA and in other inflammatory diseases associated with inflammatory joint damage.

Authors

Carmelo Carmona-Rivera, Philip M. Carlucci, Rishi R. Goel, Eddie James, Stephen R. Brooks, Cliff Rims, Victoria Hoffmann, David A. Fox, Jane H. Buckner, Mariana J. Kaplan

×

Figure 5

FLSs exposed to NETs present citrullinated cartilage proteins to CD4+ T cells and promote in vitro and in vivo adaptive immune responses to citrullinated cartilage peptides in humans and mice.

Options: View larger image (or click on image) Download as PowerPoint
FLSs exposed to NETs present citrullinated cartilage proteins to CD4+ T ...
(A) IFN-γ was measured in supernatants of RA FLSs cocultured for 5 days with cit-aggrecan–specific CD4+ T cells in the presence or absence of cit-aggrecan peptides. Results are the mean ± SEM of 5 independent experiments. Kruskal-Wallis with post hoc Dunn’s test was used. Autoantibodies against native and citrullinated forms of (B) aggrecan, (C) biglycan, and (D) clusterin were measured in OA (n = 9) and RA (n = 15) SF. Results are the mean ± SEM. Mann-Whitney U test was used. Sera from HLA-DRB1*04:01 transgenic mice immunized with FLSs or FLSs in the presence of NETs were analyzed for the presence of autoantibodies against citrullinated versions of (E) aggrecan, (F) biglycan, and (G) clusterin. Results are the mean ± SEM of n = 5 per group. Mann-Whitney U test was used. *P < 0.05, and **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts